CJC-1295 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-08-17. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
=== Purification of a tagged protein === Another way to tag proteins is to engineer an antigen peptide tag onto the protein, and then purify the protein on a column or by incubating with a loose resin that is coated with an immobilized antibody. This particular procedure is known as immunoprecipitation. Immunoprecipitation is capable of generating an extremely specific interaction which usually results in binding only the desired protein. The purified tagged proteins can then easily be separated from the other proteins in solution and later eluted back into clean solution. When the tags are not needed anymore, they can be cleaved off by a protease. This often involves engineering a protease cleavage site between the tag and the protein. Self-cleaving tags eliminate the need for proteases to separate tag from target protein of interest during purification process (e.g. iCapTag™). The main component of the tag is an intein, which cleaves off simply after a pH change. Tagless and pure target protein is then released into the elution buffer. Emerging methods in synthetic biology explore chromatography-free alternatives by harnessing liquid-liquid phase separation to create synthetic organelles within bacterial cells, such as E. coli. These approaches use phase-separated RNA structures to compartmentalize proteins, enabling in-cell organization, self-cleavage via inteins, and direct release of tag-free proteins, which leads to enhanced efficiency in recombinant protein workflows.
Until the 1960s, radioactivity was often handled naively and carelessly. From 1940 to 1945, the Berlin-based Auergesellschaft, founded by Carl Auer von Welsbach (1858-1929, Osram), produced a radioactive toothpaste called Doramad that contained thorium-X and was sold internationally. It was advertised with the statement, "Its radioactive radiation strengthens the defenses of the teeth and gums. The cells are charged with new life energy and the destructive effect of bacteria is inhibited. This gave the claim of radiant white teeth a double meaning. By 1930, there were also bath additives and eczema ointments under the brand name "Thorium-X". Radium was also added to toothpastes, such as Kolynos toothpaste. After World War I, radioactivity became a symbol of modern achievement and was considered "chic". Radioactive substances were added to mineral water, condoms, and cosmetic powders. Even chocolate laced with radium was sold. The toy manufacturer Märklin in the Swabian town of Göppingen tested the sale of an X-ray machine for children. At upper-class parties, people "photographed" each other's bones for fun. A system called Trycho (Ancient Greek: τριχο-, romanized: tricho-, lit. 'concerning the hair') for epilation (hair removal) of the face and body was franchised in the USA. As a result, thousands of women suffered skin burns, ulcers and tumors. It was not until the atomic bombings of Hiroshima and Nagasaki that the public became aware of the dangers of ionizing radiation and these products were banned.
George Wallace Kenner FRS (16 November 1922 – 26 June 1978) was a British organic chemist. He was born in Sheffield in 1922, the son of Professor James Kenner. During his childhood, he went to Didsbury Preparatory School in 1928 and moved to Manchester Grammar School in 1934. He was appointed to the first Heath Harrison Chair of Organic Chemistry at the University of Liverpool 1957–1976. He did his MSc and PhD degrees under Lord Todd at Manchester and Cambridge Universities in the UK. He married Jillian Bird in 1951 and they had two daughters both born in Cambridge. He was faculty member at Cambridge University for 11 years before moving to the University of Liverpool in 1957 as Heath Harrison Professor of Organic Chemistry.
Based on the size and histological staining characteristics of the fibrils, it is likely that at least in part they are composed of type III collagen (reticulin). An in vitro study with native collagen demonstrated that fibronectin binds to type III collagen rather than other types.
Sources: en.wikipedia.org
Black Widow Games was a video game developer specializing in promotional mods for Quake and Half-Life 3D engines. They are best known for their They Hunger series. Prominent members included Neil Manke (game and level design), Einar Saukas (game design and coding), and Magnus Jansén (game consultant and sound engineer). The company business model is based on developing contract-work mods for the marketing campaigns of customer companies and products (such as the S.O.F. TV series from Rysher Entertainment and the movie Underworld from Sony Pictures), freely distributed for promotion.
Due to its property of being a prodrug of GHB which increases sleep related growth hormone (GH) secretion, GBL was sold as a nutritional supplement after the scheduling of GHB, under the names Revivarant and Renewtrient, until they were banned by the FDA.
=== Other mammalian research === The largest mammal-like tracks from the Lower Cretaceous strata from Gondwana reported to date are described from the Botucatu Formation (Brazil) by Buck et al. (2026), expanding known size range of Early Cretaceous mammaliaforms. Redescription and a study on the affinities of Buginbaatar transaltaiensis is published by Lopatin & Averianov (2026). Lopatin & Averianov (2026) report the first discovery of fossil material of multituberculates belonging to the group Djadochtatherioidea from the Upper Cretaceous Nemegt Formation (Mongolia). New information on the endocranial anatomy of Kryptobaatar dashzevegi is provided by Macrini & Rowe (2026). Krause et al. (2026) identify fossil material of "Kimbetopsalis" simmonsae from the Paleocene strata of the Denver Formation (Colorado, United States), extending known geographical range of this species, and transfer the studied species to the genus Taeniolabis. Bishop & Pierce (2026) reconstruct the musculature of the forelimbs five non-therian synapsids, including Vincelestes neuquenianus.
Sources: en.wikipedia.org
== Further reading == Al-Hussainy, Abbas Ali Abbas, "The civilized achievements of the Akkadian king Naram-Sin A Research in his Artistic Remains and The Date Formulas", ISIN Journal 3, 2022 Boissier, Alfred, "Inscription de Naram-Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 16, no. 3, pp. 157–64, 1919 Foster, B. R., "Naram-Sin in Martu and Magan", ARRIM 8, pp. 25–44, 1990 Glassner, J. J., "Naram-Sîn Poliorcète. Les avatars d'une sentence divinatoire", Revue d’Assyriologie et d’archéologie Orientale, vol. 77, no. 1, pp. 3–10, 1983 Grayson, A. Kirk, and Edmond Sollberger, "L’insurrection générale contre Narām-Suen", RA70, pp. 103–128, 1976 Lafont, Bertrand, "Une plaque en argile portant une inscription de Naram-Sin d'Agadé", The Third Millennium. Studies in Early Mesopotamia and Syria in Honor of Walter Sommerfeld and Manfred Krebernik, hrsg. v. Arkhipov, Ilya, Kogan, Leonid, Koslova, Natalia (Cuneiform Monographs 50), pp. 408–416, 2020 Piotr Michalowski, "New Sources concerning the Reign of Naram-Sin", Journal of Cuneiform Studies, vol. 32, no. 4, pp. 233–246, (Oct., 1980) Nassouhi, Essad, "Un vase en albatre de Naram - Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 22, no. 2, pp. 91–91, 1925 [12] A. Poebel, "The ‘Schachtelsatz’ Construction of the Naram-Sîn Text RA XVI 157f.", Miscellaneous Studies, AS 14; Chicago, pp.23–42, 1947 Powell, Marvin A., "Narām-Sîn, Son of Sargon: Ancient History, Famous Names, and a Famous Babylonian Forgery", Zeitschrift für Assyriologie und Vorderasiatische Archäologie, vol. 81, no. 1-2, pp.
Born Mary Morse Baker on a farm in Bow, New Hampshire, Eddy was the youngest of six children in a family of Protestant Congregationalists. Her father, Mark Baker, was a deeply religious man, although, according to one account, "Christianity to him was warfare against sin, not a religion of human brotherhood." In common with most women at the time Eddy was given little formal education, but she said she had read widely at home. From childhood she lived with protracted ill health, complaining of chronic indigestion and spinal inflammation, and according to biographers experiencing fainting spells. The literary critic Harold Bloom described her as "a kind of anthology of nineteenth-century nervous ailments". Eddy's first husband died just before her 23rd birthday, six months after they married and three months before their son was born, leaving her penniless; as a result of her poor health she lost custody of the boy when he was four. Her second husband left her after 13 years of marriage; Eddy said that he had promised to become her child's legal guardian, but it is unclear whether he did, and Eddy lost contact with her son until he was in his thirties. (Per the legal doctrine of coverture, women in the United States could not then be their own children's guardians.) Her third husband, Asa Gilbert Eddy, died five years after they married; she believed he had been killed by malicious animal magnetism. Six years later, when she was 67 and apparently in need of loyalty and affection, she legally adopted a 41-year-old homeopath as her second son.
In August, the Federal Police (PF) launched Operations Carbono Oculto, Quasar and Tank against a multibillion-real scheme of fraud in the fuel sector and money laundering, revealing that the First Capital Command (PCC) and companies in the financial market used fintechs and transactions via PIX to move and conceal large sums. According to the investigation, the absence of oversight, intensified by the disinformation that circulated on social media about the new Federal Revenue Service oversight rule that would be implemented at the beginning of the year but was revoked due to fake news, facilitated the criminal group's activity. Later, deputies requested the investigation of Nikolas over the video in which he criticized the new oversight of financial movements via Pix."These fake news were so strong that, despite all the effort of the Federal Revenue Service, we could not overcome these lies, because of the strength of those who boosted them. [...] And today's operations show who gained from these lies, from these fake news". — Robinson Barreirinhas, special secretary of the Federal Revenue Service.
== Structural classes == Enzyme inhibitors are a chemically diverse set of substances that range in size from organic small molecules to macromolecular proteins. Small molecule inhibitors include essential primary metabolites that inhibit upstream enzymes that produce those metabolites. This provides a negative feedback loop that prevents over production of metabolites and thus maintains cellular homeostasis (steady internal conditions). Small molecule enzyme inhibitors also include secondary metabolites, which are not essential to the organism that produces them, but provide the organism with an evolutionary advantage, in that they can be used to repel predators or competing organisms or immobilize prey. In addition, many drugs are small molecule enzyme inhibitors that target either disease-modifying enzymes in the patient or enzymes in pathogens which are required for the growth and reproduction of the pathogen. In addition to small molecules, some proteins act as enzyme inhibitors. The most prominent example are serpins (serine protease inhibitors) which are produced by animals to protect against inappropriate enzyme activation and by plants to prevent predation. Another class of inhibitor proteins is the ribonuclease inhibitors, which bind to ribonucleases in one of the tightest known protein–protein interactions. A special case of protein enzyme inhibitors are zymogens that contain an autoinhibitory N-terminal peptide that binds to the active site of enzyme that intramolecularly blocks its activity as a protective mechanism against uncontrolled catalysis.
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.